PASCAL Ace with Capture Clarity Valve Repair System MR Implant System
Edwards Lifesciences, LLC · Decision date Sep 23, 2026
What did the FDA approve?
P220003/S028 is a normal 180-day track supplement to PMA P220003, approved 2026-09-23, for the PASCAL Ace with Capture Clarity Valve Repair System in the mitral valve repair device category (product code NKM). The listed supplement reason is a change to design, components, specifications, or materials. The record does not specify which design element, component, specification, or material changed, so the precise modification is unknown from these fields.
The source statement describes the action as approval of the system identified above; it does not state that the underlying PMA was newly approved or that the supplement covers the whole system afresh. The stated purpose of a design or materials change should not be read as independent evidence of safety or clinical effectiveness. Because the identifier P220003 links this supplement to the original PMA, the action is best read as a supplement to that file, not a separate original approval.
Edwards Lifesciences, LLC is the applicant. Any question about what was altered mechanically, what testing supported the change, or whether labeling or indications shifted is outside the supplied fields and cannot be answered from this record.
FDA approval order statement
Approval for the PASCAL Ace with Capture Clarity Valve Repair System.
- Regulatory pathway
- PMA supplement
- Supplement type
- Normal 180 Day Track
- Clinical specialty
- Cardiovascular
- Decision date
- Sep 23, 2026
- FDA change category
- Change Design/Components/Specifications/Material
FDA source record · MedtechLedger’s explanation describes the recorded change.
Regulatory record facts
- Identifier
- P220003/S028
- Regulatory pathway
- PMA supplement
- Applicant
- Edwards Lifesciences, LLC
- Product code
- NKM
- Decision code
- APPR
- Decision date
- Sep 23, 2026
- Source update
- Nov 9, 2026
- Original record
- Open FDA source record
About this medical device
FDA device category: Mitral valve repair devices.
- Applicant
- Edwards Lifesciences, LLC
- Product code
- NKM
- FDA device class
- 3
For the original device and its historical approval scope, see PMA P220003. Subsequent supplements may change the device or its indications.
FDA decision timeline
P220003 · Original PMA
PASCAL Precision Transcatheter Valve Repair System
P220003/S028 received
Application receipt date recorded by FDA.
P220003/S033 · Related supplement
PASCAL Precision Transcatheter Valve Repair System
P220003/S028 · FDA decision
Normal 180 Day Track
P220003/S029 · Related supplement
PASCAL Precision Transcatheter Valve Repair System
P220003/S032 · Related supplement
PASCAL Precision Transcatheter Valve Repair System
Timeline entries are records held by MedtechLedger for P220003. View FDA’s full supplement list.
Related devices and submissions
Same PMA: P220003
| Product / regulatory record | Company | Pathway | Decision date | Source |
|---|---|---|---|---|
| Edwards Lifesciences, LLC | PMA approval | Sep 14, 2022 | FDA | |
| Edwards Lifesciences, LLC | PMA supplement | Sep 9, 2026 | FDA | |
| Edwards Lifesciences, LLC | PMA supplement | Oct 20, 2026 | FDA | |
| Edwards Lifesciences, LLC | PMA supplement | Oct 22, 2026 | FDA |
Regulatory context
A PMA supplement records a change to a device with an existing premarket approval. The supplement’s approval applies to the change described in that submission.
Read our guide to FDA clearance and approval · FDA’s explanation of this pathway
Manufacturer intelligence
Edwards Lifesciences, LLC
- Headquarters
- Not reported
- Brand website
- Not reported
- FDA applicant address
- One Edwards Way, Irvine, CA, 92614
Sources and methodology
- Original FDA record: P220003/S028
- openFDA source data · Source release Nov 9, 2026 · Retrieved Nov 19, 2026
FDA fields and approval-order wording are presented as source information. MedtechLedger explanations are identified separately and describe the scope of the recorded decision. Indications from an original PMA are historical unless confirmed against subsequent labeling and supplements.
How we use FDA records